Showing results (2781-2790 of 3,353) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|June 7, 1992
Comparison of prescribing habits of general practitioners in The Netherlands versus England and WalesF M Hull, R F Westerman, R Jonkers
Pharmacoeconomics|December 9, 1992
The formulary decision-making process in a US academic medical centreD B Nash, M L Catalano, C J Wordell
Pharmacoeconomics|June 6, 1997
Publication bias in clinical trials and economic analysesN Freemantle, J Mason
Pharmacoeconomics|June 6, 1997
Cost effectiveness of the prevention and treatment of deep vein thrombosis and pulmonary embolismD R Anderson, B J O'Brien
Pharmacoeconomics|June 6, 1997
Analysis of the costs of NSAID-associated gastropathy. Experience in a US health maintenance organisationR E Johnson, M C Hornbrook, R S Hooker, et al.
Pharmacoeconomics|June 6, 1997
Cost-utility analysis of melphalan plus prednisone with or without interferon-alpha 2b in newly diagnosed multiple myeloma. Results from a randomised controlled trialE Nord, F Wisløff, M Hjorth, et al.
Pharmacoeconomics|October 4, 1996
A cost-utility analysis of second-line chemotherapy in metastatic breast cancer. Docetaxel versus paclitaxel versus vinorelbineR Launois, J Reboul-Marty, B Henry, et al.
Pharmacoeconomics|July 6, 1997
The use of consensus methods and expert panels in pharmacoeconomic studies. Practical applications and methodological shortcomingsC Evans
Pharmacoeconomics|July 6, 1997
A review of quality of life in chronic renal failureD S Parsons, D C Harris
Pharmacoeconomics|July 6, 1997
Cost effectiveness in the treatment of heart failure with ramipril. A Swedish substudy of the AIRE study. Acute Infarction Ramipril EfficacyL Erhardt, S Ball, F Andersson, et al.
Pageof 336